A Phase III Randomized Study To Investigate The Efficacy And Safety Of Atezolizumab (Antipdl1 Antibody) In Combination With Neoadjuvant Anthracycline/Nabpaclitaxelbased Chemotherapy Compared With Placebo And Chemotherapy In Patients With Primary Invasive Triplenegative Breast Cancer

Project: Research

Project Details

Project Description

NMA HREC Reference Number: SSA/17/MonH/446 - HREC/17/HAWKE/260
Monash Health Ref: RES-17-0000514A

Effective start/end date14/12/1813/12/23